While the economy sputters, the long acting bronchodilator/ corticosteroid combination inhaler market is booming. While big ... Read more »
This is something that has been discussed a lot in asthma communities, as you can see here. Yet there has been very little documented... Read more »
Asthma treatment is all about control. Control is the main goal of asthma treatment, as outlined in both the U.S. asthma management... Read more »
So, you've been diagnosed with asthma for the first time as an older adult? Well, welcome to an ever-growing club! More and more older... Read more »
Even during my short lifespan the definition of asthma has changed quite a bit. It's important we asthmatics keep up on the current... Read more »
Have questions or comments? Click here. Last week the Food and Drug Administration (FDA) listened to presentations and comments from several members... Read more »
New data suggests that asthma drug Symbicort might be more cost- effective than Advair in the management of Chronic Obstructive Pulmonary disease... Read more »
Advair maker GlaxoSmithKline has asked European regulators to change the popular asthma drug's labels so that they include the drug's benefits for... Read more »
The U.S. Food and Drug Administration (FDA) is again concerned about the safety of four popular asthma inhalers. Two federal safety officials wrote... Read more »
This is a study sponsored by GlaxoSmithKline to determine the relationship between asthma and genetics in patients using Advair and Serevent. This... Read more »